Lactic Acid Bacteria
A Functional Approach
Herausgeber: Albuquerque Cavalcanti de Albuquerque, M.; LeBlanc, Jean Guy; de Moreno de LeBlanc, Alejandra
Lactic Acid Bacteria
A Functional Approach
Herausgeber: Albuquerque Cavalcanti de Albuquerque, M.; LeBlanc, Jean Guy; de Moreno de LeBlanc, Alejandra
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book explores advances in new promising Lactic Acid Bacteria (LAB) functionalities such as the effect on vitamin D receptor expression and the impact on neurodegeneratives pathologies. An update in the use of lactic acid bacteria and probiotics technologies to develop new functional foods and functional pharmaceutical and cosmetic products is also provided.
Andere Kunden interessierten sich auch für
- Dietary Supplements in Health Promotion68,99 €
- The Physiological Basis of Metabolic Bone Disease105,99 €
- Jana ParizkovaChildhood Obesity Prevention and Treatment92,99 €
- George A BrayA Guide to Obesity and the Metabolic Syndrome103,99 €
- Healthful Eating As Lifestyle (HEAL)68,99 €
- Nutrition Support for the Critically Ill Patient68,99 €
- Arthritis87,99 €
-
-
-
This book explores advances in new promising Lactic Acid Bacteria (LAB) functionalities such as the effect on vitamin D receptor expression and the impact on neurodegeneratives pathologies. An update in the use of lactic acid bacteria and probiotics technologies to develop new functional foods and functional pharmaceutical and cosmetic products is also provided.
Produktdetails
- Produktdetails
- Verlag: Bsp Books Pvt. Ltd.
- Seitenzahl: 292
- Erscheinungstermin: 30. Juni 2021
- Englisch
- Abmessung: 234mm x 156mm x 16mm
- Gewicht: 422g
- ISBN-13: 9780367496258
- ISBN-10: 0367496259
- Artikelnr.: 69894444
- Verlag: Bsp Books Pvt. Ltd.
- Seitenzahl: 292
- Erscheinungstermin: 30. Juni 2021
- Englisch
- Abmessung: 234mm x 156mm x 16mm
- Gewicht: 422g
- ISBN-13: 9780367496258
- ISBN-10: 0367496259
- Artikelnr.: 69894444
Marcela Albuquerque Cavalcanti de Albuquerque Marcela Albuquerque Cavalcanti de Albuquerque, PhD and MSc in Sciences (USP and UFRJ, Brazil), BSc in Biological Sciences (UNIRIO, Brazil), is a Researcher (USP, Brazil) and a scientific-based Entrepreneur. Her principle areas of study include the use of lactic acid bacteria to increase B-vitamin content in foods and to develop hypoallergenic foods; probiotics and prebiotics. She has published peer-reviewed articles, book chapters and works in scientific meetings. Alejandra de Moreno de LeBlanc Alejandra de Moreno de LeBlanc, PhD in Biochem. (UN Tucuman, Argentina), is an Independent Researcher (CERELA-CONICET, Argentina). Her principle areas of study include the evaluation of lactic acid bacteria as modulators of the host immune response in cancer, inflammatory diseases and neurodegenerative diseases. She has edited 2 books, published 80 peer-reviewed articles, 23 book chapters and 113 works in scientific meetings. Jean Guy LeBlanc Jean Guy LeBlanc, PhD in Biochem. (UN Tucuman, Argentina), MSc and BSc in Biochem. (U. Moncton, Canada), is a Principal Researcher (CERELA-CONICET, Argentina). His principle areas of study include the use of lactic acid bacteria to increase bioactive compounds in foods or as bio-pharmaceuticals to treat and prevent vitamin deficiencies and inflammatory diseases. He has edited 7 books, published 94 peer-reviewed articles, 30 book chapters and 135 works in scientific meetings. Raquel Bedani Raquel Bedani has a MSc and PhD in Food and Nutrition at São Paulo State University (UNESP, Brazil) and also holds a BSc in Biological Sciences (UNESP). Part of her doctoral study was done at Reference Center for Lactobacilli (CERELA, Argentina). Raquel developed postdoctoral research at University of São Paulo (USP, Brazil). She has several publications in peer-reviewed journals and book chapters. Her main field of research includes the development of probiotic and prebiotic foods and the evaluation of their effects on health.
Probiotic legislation and dose response. Vitamin production by lactic acid
bacteria: the effect on vitamin content in foods and in human microbiota.
Impact of probiotics on vitamin D receptor expression. Impact of probiotics
on inflammatory bowel disease and irritable bowel syndrome. The potential
use of lactic acid bacteria in neurodegenerative pathologies. Lactic acid
bacteria bacteriocins and their impact on human microbiota. Effect of short
chain fatty acids produced by probiotics on metabolism. Metabolites of
polyphenols produced by probiotic microorganisms and their beneficial
effects on health. Impact of probiotics on cardiovascular disease. Impact
of probiotics on metabolic disorders (obesity, diabetes type 2). Impact of
probiotics on animal health. Probiotics and quorum sensing: potential
mechanisms. Anti-allergenic effect of probiotics on food
bacteria: the effect on vitamin content in foods and in human microbiota.
Impact of probiotics on vitamin D receptor expression. Impact of probiotics
on inflammatory bowel disease and irritable bowel syndrome. The potential
use of lactic acid bacteria in neurodegenerative pathologies. Lactic acid
bacteria bacteriocins and their impact on human microbiota. Effect of short
chain fatty acids produced by probiotics on metabolism. Metabolites of
polyphenols produced by probiotic microorganisms and their beneficial
effects on health. Impact of probiotics on cardiovascular disease. Impact
of probiotics on metabolic disorders (obesity, diabetes type 2). Impact of
probiotics on animal health. Probiotics and quorum sensing: potential
mechanisms. Anti-allergenic effect of probiotics on food
Probiotic legislation and dose response. Vitamin production by lactic acid
bacteria: the effect on vitamin content in foods and in human microbiota.
Impact of probiotics on vitamin D receptor expression. Impact of probiotics
on inflammatory bowel disease and irritable bowel syndrome. The potential
use of lactic acid bacteria in neurodegenerative pathologies. Lactic acid
bacteria bacteriocins and their impact on human microbiota. Effect of short
chain fatty acids produced by probiotics on metabolism. Metabolites of
polyphenols produced by probiotic microorganisms and their beneficial
effects on health. Impact of probiotics on cardiovascular disease. Impact
of probiotics on metabolic disorders (obesity, diabetes type 2). Impact of
probiotics on animal health. Probiotics and quorum sensing: potential
mechanisms. Anti-allergenic effect of probiotics on food
bacteria: the effect on vitamin content in foods and in human microbiota.
Impact of probiotics on vitamin D receptor expression. Impact of probiotics
on inflammatory bowel disease and irritable bowel syndrome. The potential
use of lactic acid bacteria in neurodegenerative pathologies. Lactic acid
bacteria bacteriocins and their impact on human microbiota. Effect of short
chain fatty acids produced by probiotics on metabolism. Metabolites of
polyphenols produced by probiotic microorganisms and their beneficial
effects on health. Impact of probiotics on cardiovascular disease. Impact
of probiotics on metabolic disorders (obesity, diabetes type 2). Impact of
probiotics on animal health. Probiotics and quorum sensing: potential
mechanisms. Anti-allergenic effect of probiotics on food